Back to search

Article

COVID-19 Booster Doses Reduce Sex Disparities in Antibody Responses among Nursing Home Residents

2024-10-23

Abstract excerpt

<h4>Background: </h4> Data suggests that antibody responses following COVID-19 vaccines are a correlate of protection. Some studies, including the clinical trials of COVID-19 mRNA vaccines, did not stratify and evaluate whether antibody responses to COVID-19 vaccines differed between the sexes or with aging. This gap in research is particularly relevant for older populations such as nursing home residents (NHR). W...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c2a694e9-4c13-5ae3-b12e-48c7a864d557
DOI
10.1101/2024.10.23.24315989
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
COVID-19 Booster Doses Reduce Sex Disparities in Antibody Responses among Nursing Home ResidentsDOI 10.1101/2024.10.23.24315989
Durability of immunity and clinical protection in nursing home residents following bivalent SARS-CoV-2 vaccinationSemantic proximity
Kinetics of COVID-19 mRNA primary and booster vaccine-associated neutralizing activity against SARS-CoV-2 variants of concern in long-term care facility residents: A prospective longitudinal studySemantic proximity
Determinants of early antibody responses to COVID-19 mRNA vaccines in exposed and naive healthcare workersSemantic proximity
Neutralizing antibody responses to SARS-CoV-2 variants in vaccinated Ontario long-term care home residents and workersSemantic proximity
Adjusted booster schedules disperse age-dependent differences in antibody titers benefitting risk populationsSemantic proximity
Neutralizing antibodies to SARS-CoV-2 Omicron variant after 3 <sup>rd</sup> mRNA vaccination in health care workers and elderly subjects and response to a single dose in previously infected adultsSemantic proximity
Outbreak of SARS-CoV-2 B.1.617.2 (Delta) variant in a Nursing Home 28 weeks after two doses of mRNA anti-Covid-19 vaccines: evidence of a waning immunitySemantic proximity
Booster Vaccination Strongly Enhances SARS-CoV-2-Specific Antibody and Cellular Responses in Elderly Residents of Care HomesSemantic proximity
Health Characteristics Associated With Persistence of SARS-CoV-2 Antibody Responses After Repeated Vaccinations in Older Persons Over Time: The Doetinchem Cohort StudySemantic proximity
Immunogenicity of a BNT162b2 Vaccine Booster Against SARS-CoV-2 Delta and Omicron Variants in Older PeopleSemantic proximity
Titers and capacity of neutralizing antibodies against SARS-CoV-2 variants after heterologous booster vaccination in health care workers primed with two doses of ChAdOx1 nCov-19: a single-blinded, randomized clinical trialSemantic proximity
Competent immune responses to SARS-CoV-2 variants in older adults following mRNA vaccinationSemantic proximity
Select a neighboring publication to make it the new centre.